Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
INTERCEPT PHARMACEUTICALS, INC. (ICPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 5% stake in Intercept Pharmaceuticals Inc. |
| 07/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 11.3% stake in Intercept Pharmaceuticals Inc. |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.5% stake in INTERCEPT PHARMACEUTICALS, INC. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.9% stake in Intercept Pharmaceuticals, Inc. |
| 02/02/2023 |
SC 13G/A
| STATE STREET CORP reports a 7.7% stake in AMEMDED FILING INTERCEPT PHARMACEUTICALS INC |
| 01/13/2023 |
SC 13G/A
| MILLENNIUM MANAGEMENT LLC reports a 2.4% stake in INTERCEPT PHARMACEUTICALS, INC. |
| 10/11/2022 |
SC 13G/A
| FMR LLC reports a 2.4% stake in INTERCEPT PHARMACEUTICALS INC |
| 09/02/2022 |
SC 13G/A
| Genextra S.p.A. reports a 13.4% stake in INTERCEPT PHARMACEUTICALS, INC. |
| 02/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 11% stake in AMENDED FILING INTERCEPT PHARMACEUTICALS INC |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.7% stake in Intercept Pharmaceuticals Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
SC 13G/A
| FIRST TRUST PORTFOLIOS LP reports a 0% stake in Intercept Pharmaceuticals, Inc. |
| 12/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in INTERCEPT PHARMACEUTICALS, INC. |
| 08/31/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/15/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 15% stake in INTERCEPT PHARMACEUTICALS INC |
| 07/31/2019 |
SC 13G/A
| Genextra S.p.A. reports a 20.6% stake in ————————————— INTERCEPT PHARMACEUTICALS, INC. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2019 |
SC 13G/A
| Genextra S.p.A. reports a 20.6% stake in ————————————— INTERCEPT PHARMACEUTICALS, INC. |
| 12/07/2018 |
SC 13G/A
| JPMORGAN CHASE & CO reports a 4.3% stake in INTERCEPT PHARMACEUTICALS, INC. |
| 04/12/2018 |
SC 13G/A
| Genextra S.p.A. reports a 23.3% stake in INTERCEPT PHARMACEUTICALS, INC. |
| 02/13/2018 |
SC 13G/A
| Capital World Investors reports a 4.6% stake in Intercept Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/09/2017 |
SC 13G/A
| AMERIPRISE FINANCIAL INC reports a 4.7% stake in Intercept Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|